 |
Hear from one of the top liver cancer experts, Josep Llovet, M.D., on how support from the Samuel Waxman Cancer Research Foundation is helping to make a difference against this deadly disease. |
 |
The Samuel Waxman Cancer Research Foundation awards research grants to some of the best scientific minds in differentiation therapy and epigenetics all over the world.
|
 |
Nabeel Bardeesy, Ph.D., of Massachusetts General Hospital Cancer Center is conducting vital research in pancreatic cancer. Funding from both the Waxman Foundation and the Pancreatic Cancer Action Network has furthered Bardeesy's critical work to find clues against this deadly disease.
|
 |
Gwen Darien, the Executive Director of the Samuel Waxman Cancer Research Foundation, shares how she became involved in cancer research advocacy.
|
 |
The Millennial Society of the Samuel Waxman Cancer Research Foundation is dedicated to raising awareness about the Foundation. The goal of the Society is to raise funds to support research in young adult cancers.
|
 |
Stephen Baylin, M.D., a professor in oncology at the Johns Hopkins University School of Medicine, is a pioneer in the field of epigenetics. He discusses how researchers are learning the way genes are turned on and off to deliver therapies to cancer patients in a new way.
|
 |
Cancer researcher Robert A. Weinberg, Ph.D., co-founder of the Whitehead Institute for Biomedical Research in Cambridge, Mass., who discovered the first human oncogene, explains the importance of cancer stem cells and the role they play in the spread of cancer, including breast cancer.
|
 |
Jonathan Licht, M.D., an associate scientific director of the Samuel Waxman Cancer Research Foundation, explains how investigators have deepened their understanding of cancer research over the years.
|
 |
The Samuel Waxman Cancer Research Foundation (SWCRF) has awarded 13 collaborative research grants and 3 individual research grants, totaling $1.54 million.
|
 |
Listen to our new podcast with Alan Ashworth, who helped discover the BRCA2 breast cancer gene in 1995. Ashworth is the recipient of the Fifth David T. Workman Memorial Award from the Samuel Waxman Cancer Research Foundation.
|
 |
Samuel Waxman, M.D., the Scientific Director and Founder of the Samuel Waxman Cancer Research Foundation, explains the unique concepts that set the Foundation apart in cancer research.
|